A Japanese Multicenter Database Study of Retroperitoneal Sarcoma: Outcomes of Patients Receiving Eribulin Therapy
We separately described outcomes and treatment patterns of patients with resectable and unresectable RPS. Our findings suggest that eribulin should be considered a treatment option for unresectable RPS in clinical practice.
Authors
- Keiichi Sakamoto
- Atsushi Tomioka (ORCID: https://orcid.org/0000-0001-7008-1502)
- Yoshiaki Matsumura (ORCID: https://orcid.org/0000-0001-5873-0346)
- Masaomi Kuwada
- Fumisato Maesaka (ORCID: https://orcid.org/0000-0001-7754-7184)
- T. Fujii (ORCID: https://orcid.org/0000-0003-0608-237X)
- Motokiyo Yoshikawa
- Yusuke Iemura
- Yuki Oda
- Kota Iida
- Nobutaka Nishimura
- Yuta Toyoshima
- Kiyohide Fujimoto
- Takashi Iwamoto
- Makito Miyake
Institutions
- Tenri Hospital (JP)
- Osaka Kaisei Hospital (JP)
- Osaka Neurological Institute (JP)
- Nara City Hospital (JP)
- Tane General Hospital (JP)
- Jikei University Kashiwa hospital (JP)
- Yamato Municipal Hospital (JP)
- Nara Medical University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Asia-Pacific Journal of Clinical Oncology
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1111/ajco.70080
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00